ClinicalTrials.Veeva

Menu

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets (QUEST)

Pfizer logo

Pfizer

Status

Completed

Conditions

Alzheimer Disease

Treatments

Other: No intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT01089582
A2501054

Details and patient eligibility

About

This study assessed the Hr QoL (Health related Quality of life) of subjects with mild to moderate AD, who received ARICEPT under usual clinical practice.

Full description

This non-interventional study enrolled patients with mild to moderate dementia of the Alzheimer's type, who have been prescribed treatment with ARICEPT under usual clinical practice.

Enrollment

628 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Alzheimer's Disease

Exclusion criteria

  • There are no exclusion criteria

Trial design

628 participants in 1 patient group

AD patients
Treatment:
Other: No intervention

Trial contacts and locations

29

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems